Reversible lansoprazole-induced interstitial lung disease showing improvement after drug cessation

Kyu Won Hwang, Hee Woo Ok, Seok Yong Hwan, Kyung Shin Bong, Jeong Shim Jae, Eun Young Kang

    Research output: Contribution to journalArticlepeer-review

    5 Citations (Scopus)

    Abstract

    Lansoprazole is an acid proton-pump inhibiting drug that is used for the treatment of duodenal or gastric ulcers, H. pylori infection, gastroesophageal reflux disease or Zollinger-Ellison syndrome. Although lansoprazole is well known for its gastrointestinal and dermatologic adverse effects, mild pulmonary symptoms are also known to develop from taking this drug. There have been no reports about lansoprazole-induced interstitial lung disease. We report here a case of lansoprazole-induced interstitial lung disease that developed in a 66-year-old man.

    Original languageEnglish
    Pages (from-to)175-178
    Number of pages4
    JournalKorean journal of radiology
    Volume9
    Issue number2
    DOIs
    Publication statusPublished - 2008 Apr

    Keywords

    • Computed tomography (CT)
    • Interstitial lung disease
    • Lansoprazole

    ASJC Scopus subject areas

    • Radiology Nuclear Medicine and imaging

    Fingerprint

    Dive into the research topics of 'Reversible lansoprazole-induced interstitial lung disease showing improvement after drug cessation'. Together they form a unique fingerprint.

    Cite this